Good afternoon, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to introduce CEO of Cooper Companies, Al White. Al will do a presentation followed by some Q&A. Al? Great.

Experts will present new consumer and professional data about opticianry’s role in contact lens practice and patient success.

The contact lens manufacturer has confirmed the introduction of MyDay MiSight 1 day, which will be available in market in the ...

New Lenses Combine Advanced Silicone Hydrogel Material with Proven ActivControl Technology *1 to Slow the Worsening of Myopia in Children †2,3 FAREHAM, England, Jan. 6, 2026 /PRNewswire/ -- ...

To learn more about this innovation and CooperVision's evidence-based myopia management portfolio, visit www.coopervision.co.uk. About CooperVisionCooperVision, a division of CooperCompanies (Nasdaq: ...

SAN RAMON, Calif., Nov. 18, 2019 /PRNewswire/ -- CooperVision announced today it has received U.S. Food and Drug Administration (FDA) approval of its innovative MiSight® 1 day contact lens1. The ...

The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only ...

A series of three panel discussions will be held during the show, exploring three macro trends set to shape the sector in the ...

Teresa Sanchez was in Mexico for a medical procedure nearly four years ago when she kept feeling dry, poking sensations in her right eye. She chalked it up to a potential rip in her contact lens, the ...

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...

I've been writing, editing and optimizing search content for 10 years. I consider 1-800 Contacts as the best place to buy contacts overall thanks to its variety, Best Price Guarantee and ridiculously ...

The event highlighted ECPs’ role in guiding families, personalizing care, and achieving long-term myopia outcomes.